SCHEMBL1015527

SCHEMBL1015527

O=C(C=CCN1CCOCC1)N1CCc2c(sc3ncnc(Nc4ccc(OCc5cnccn5)c(Cl)c4)c23)C1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015526 1.00 EGFR (0.70) EGFR
SCHEMBL1016332 0.94 EGFR (0.65) EGFR
SCHEMBL1016331 0.94 EGFR (0.65) EGFR
SCHEMBL1017405 0.94 EGFR (0.64) EGFR
SCHEMBL1017406 0.94 EGFR (0.64) EGFR
SCHEMBL1016217 0.92 EGFR (0.70) EGFR
SCHEMBL1016216 0.92 EGFR (0.70) EGFR
SCHEMBL1017540 0.91 EGFR (0.69) EGFR
SCHEMBL1017542 0.91 EGFR (0.69) EGFR
SCHEMBL1016863 0.88 EGFR (0.75) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed